1. Eli Lilly and Company
2. AbbVie Inc.
3. AstraZeneca plc
4. Boehringer Ingelheim GmbH
5. Celgene Corporation
6. Novartis AG
7. Sanofi SA
8. Takeda Pharmaceutical Company Limited
9. Mylan N.V.
10. Amgen Inc
Published | Pages | Publisher | Report code |
---|---|---|---|
Nov 2023 | 181 | TechSci Research | ASDR-640768 |
1. Eli Lilly and Company
2. AbbVie Inc.
3. AstraZeneca plc
4. Boehringer Ingelheim GmbH
5. Celgene Corporation
6. Novartis AG
7. Sanofi SA
8. Takeda Pharmaceutical Company Limited
9. Mylan N.V.
10. Amgen Inc